Envestnet Portfolio Solutions
TGTX icon

Envestnet Portfolio Solutions’s TG Therapeutics TGTX Stock Holding History

Envestnet Portfolio Solutions’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
21,192
+4,215
+25% +$173K 0.01% 645
2026
Q1 		$564K Sell
16,977
-1,007
-6% -$30K ﹤0.01% 850
2025
Q4 		$536K Buy
17,984
+4,083
+29% +$133K ﹤0.01% 1022
2025
Q3 		$502K Sell
13,901
-1,188
-8% -$39.1K ﹤0.01% 1028
2025
Q2 		$543K Buy
+15,089
New +$562K ﹤0.01% 1059
2025
Q1 		– Sell
-7,177
Closed -$216K – 1761
2024
Q4 		$216K Buy
+7,177
New +$206K ﹤0.01% 1647

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Envestnet Portfolio Solutions's TGTX Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its TG Therapeutics (TGTX) stake by 25% in Q2 2026, buying an estimated $173K and bringing the position to 21,192 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #645.

Envestnet Portfolio Solutions first reported a position in TGTX in Q4 2024 and has held it in 6 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Envestnet Portfolio Solutions held 21,192 shares of TG Therapeutics worth $1.16M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 4,215 TG Therapeutics shares in Q2 2026, an estimated $173K.
  • TG Therapeutics made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #645 holding.
  • Envestnet Portfolio Solutions first reported a position in TG Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.